Form 8-K - Current report:
SEC Accession No. 0001683168-26-004481
Filing Date
2026-06-03
Accepted
2026-06-03 09:00:15
Documents
12
Period of Report
2026-05-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT valion_8k.htm   iXBRL 8-K 50345
2 SECOND AMENDMENT 2021 EQUITY INCENTIVE PLAN valion_ex1001.htm EX-10.1 6568
  Complete submission text file 0001683168-26-004481.txt   226892

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vbio-20260528.xsd EX-101.SCH 2990
4 XBRL LABEL FILE vbio-20260528_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE vbio-20260528_pre.xml EX-101.PRE 22342
15 EXTRACTED XBRL INSTANCE DOCUMENT valion_8k_htm.xml XML 3206
Mailing Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205 (888)276-6888
Valion Bio, Inc. (Filer) CIK: 0001787740 (see all company filings)

EIN.: 814016391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41052 | Film No.: 261059136
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)